Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04298905 · ClinicalTrials.gov registry record · NA

Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA

A NA study of HIV/AIDS and Adherence, Patient, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT04298905: Active NA study of HIV/AIDS and Adherence, Patient, sponsored by Johns Hopkins University.

NCT04298905 is a NA study of HIV/AIDS and Adherence, Patient that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 62 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04298905, a NA study of HIV/AIDS and Adherence, Patient, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

mHealth solutions designed to support affordable human resources for health, such as community health workers (CHWs), offer the opportunity to reimagine a patient-centered, system-level solution that may radically change care models in low resource settings. The 'leap' of m-health is most potent and practical in settings where desktop-based infrastructure is lacking and hard-wired internet connectivity is unavailable. Investigators have demonstrated the feasibility of mHealth and human resource solutions in South Africa and shown marked improvements in screening, linkage and treatment initiation as well as supporting patient adherence through video DOT (vDOT) and early identification of treatment related toxicity. Investigators' strategies have evaluated solutions for individual cascade steps through TB and HIV smartphone and tablet-based m-health applications implemented by a CHW. This study combines these individual cascade step approaches into an innovative TB/HIV cascade intervention study entitled, "Leveraging mHealth to enable and adapt community health worker strategies to improve TB/HIV patient outcomes in South Africa (LEAP-TB-SA) Trial."

Primary Outcome

Treatment success is defined as cure and completion of treatment.

Interventions

  • OTHER CHW mHealth patient intervention for trigger escalation

Study Locations (1)

Maryland

  • Kelly Lowensen - Baltimore

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2022-03-10
Est. Completion 2026-12-31
Phase NA
Johns Hopkins University

1,448 total trials

What the registry record for NCT04298905 still lists

NCT04298905 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which CHW mHealth patient intervention for trigger escalation is the first listed.

NCT04298905 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT04298905 about?

NCT04298905 is a clinical study titled "Leveraging mHealth to Enable and Adapt CHW Strategies to Improve TB/HIV Patient Outcomes in SA". mHealth solutions designed to support affordable human resources for health, such as community health workers (CHWs), offer the opportunity to reimagine a patient-centered, system-level solution that may radically change care models in low resource settings. The 'leap' of m-health is most potent and...

What is the current status of trial NCT04298905?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 62 participants. The study started on 2022-03-10. Estimated completion is 2026-12-31.

What conditions does trial NCT04298905 study?

This clinical trial studies the following conditions: HIV/AIDS, Adherence, Patient, Care Coordination, TB.

What interventions are being tested in trial NCT04298905?

The interventions under investigation include: CHW mHealth patient intervention for trigger escalation (OTHER).

Who is sponsoring clinical trial NCT04298905?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04298905 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04298905's enrollment target sits among peer trials

62 42nd of 61 higher than 20 of 61 other HIV/AIDS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03231150 · 62 participants · NA

    Plantar Fasciitis Randomized Clinical Control Trial

  • NCT03458676 · 62 participants · NA

    Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies

  • NCT03596086 · 62 participants · Phase 1

    HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

  • NCT03603405 · 62 participants · Phase 1

    HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04298905, the US trial registry maintained by the National Library of Medicine. NCT04298905 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.